Literature DB >> 30144311

New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette-Guerin treatment for bladder cancer: A case study.

Long Davalos1, Hani Kushlaf1.   

Abstract

Entities:  

Keywords:  BCG; bladder cancer; immune-related adverse event; intravesical BCG; myasthenia gravis; neuromuscular junction disorder

Mesh：

Substances：

Year:  2018        PMID： 30144311     DOI： 10.1002/mus.26328

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  3 in total

Review 1.  Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.

Authors:  Giulio Sansone; Domenico Marco Bonifati
Journal:  J Neurol       Date:  2022-05-03       Impact factor: 6.682

2.  SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.

Authors:  Sithara Ramdas; Ryan Malcolm Hum; Abigail Price; Anna Paul; Jeremy Bland; Georgina Burke; Maria Farrugia; Jacqueline Palace; Alice Storrie; Pauline Ho; Emma Standing; James B Lilleker; Heinz Jungbluth
Journal:  Neuromuscul Disord       Date:  2022-09-05       Impact factor: 3.538

3.  Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment.

Authors:  Anouck Becker; Iris Quasar Grunwald; Marcus M Unger; Stefanie Behnke; Joerg Spiegel; Umut Yilmaz; Silke Walter; Klaus Faßbender
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.